Contract 75A50123C00022
Melinta Therapeutics, Llc · Department Of Health And Human Services · September 5, 2024
Melinta Therapeutics, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 5, 2024 for $25.95 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Washington, DC. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost sharing contract pricing. The most recent modification was on September 25, 2025. If all options are exercised, the contract could reach $164.30 million.
Contract details
- PIID
- 75A50123C00022
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care - Other; R&D Administrative Expenses
- Place of performance
- Washington, DC
- First action
- September 5, 2024
- Latest action
- September 25, 2025
Description
THE PURPOSE OF THIS MODIFICATION IS TO IS EXERCISE AND FULLY FUND CLIN0002/OPTION 1
Modification timeline
-
September 25, 2025Mod P00005 · Exercise An Option$47.52M
-
September 12, 2025Mod P00004 · Exercise An OptionTHE PURPOSE OF THIS MODIFICATION IS TO IS EXERCISE AND FULLY FUND OPTION 5/CLIN0004, PROVIDE SUPPLEMENTAL FUNDING FOR CLIN0001 AND CLIN0003, REVISE THE BUDGET AND PERIOD OF PERFORMANCE FOR CLIN0006, A…$38.97M
-
September 5, 2024Mod P00002 · Exercise An OptionEXERCISE CLIN 0004 OPTION$26.19M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123C00022?
Contract 75A50123C00022 is a federal contract awarded to Melinta Therapeutics, Llc by Department Of Health And Human Services on September 5, 2024 for $25.95 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75A50123C00022?
Melinta Therapeutics, Llc won contract 75A50123C00022 from Department Of Health And Human Services.
How much is contract 75A50123C00022 worth?
Contract 75A50123C00022 has obligated $25.95 million to date, with a total potential value of $164.30 million if all options are exercised.